Cargando…

Using Diagnoses to Estimate Health Care Cost Risk in Canada

Until recently, the options for summarizing Canadian patient complexity were limited to health risk predictive modeling tools developed outside of Canada. This study aims to validate a new model created by the Canadian Institute for Health Information (CIHI) for Canada’s health care environment. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yin, Weir, Sharada, Steffler, Mitch, Shaikh, Shaun, Wright, James G., Kantarevic, Jasmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798736/
https://www.ncbi.nlm.nih.gov/pubmed/31567859
http://dx.doi.org/10.1097/MLR.0000000000001203
_version_ 1783460125137174528
author Li, Yin
Weir, Sharada
Steffler, Mitch
Shaikh, Shaun
Wright, James G.
Kantarevic, Jasmin
author_facet Li, Yin
Weir, Sharada
Steffler, Mitch
Shaikh, Shaun
Wright, James G.
Kantarevic, Jasmin
author_sort Li, Yin
collection PubMed
description Until recently, the options for summarizing Canadian patient complexity were limited to health risk predictive modeling tools developed outside of Canada. This study aims to validate a new model created by the Canadian Institute for Health Information (CIHI) for Canada’s health care environment. RESEARCH DESIGN: This was a cohort study. SUBJECTS: The rolling population eligible for coverage under Ontario’s Universal Provincial Health Insurance Program in the fiscal years (FYs) 2006/2007–2016/2017 (12–13 million annually) comprised the subjects. MEASURES: To evaluate model performance, we compared predicted cost risk at the individual level, on the basis of diagnosis history, with estimates of actual patient-level cost using “out-of-the-box” cost weights created by running the CIHI software “as is.” We next considered whether performance could be improved by recalibrating the model weights, censoring outliers, or adding prior cost. RESULTS: We were able to closely match model performance reported by CIHI for their 2010–2012 development sample (concurrent R(2)=48.0%; prospective R(2)=8.9%) and show that performance improved over time (concurrent R(2)=51.9%; prospective R(2)=9.7% in 2014–2016). Recalibrating the model did not substantively affect prospective period performance, even with the addition of prior cost and censoring of cost outliers. However, censoring substantively improved concurrent period explanatory power (from R(2)=53.6% to 66.7%). CONCLUSIONS: We validated the CIHI model for 2 periods, FYs 2010/2011–2012/2013 and FYs 2014/2015—2016/2017. Out-of-the-box model performance for Ontario was as good as that reported by CIHI for the development sample based on 3-province data (British Columbia, Alberta, and Ontario). We found that performance was robust to variations in model specification, data sources, and time.
format Online
Article
Text
id pubmed-6798736
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-67987362019-11-18 Using Diagnoses to Estimate Health Care Cost Risk in Canada Li, Yin Weir, Sharada Steffler, Mitch Shaikh, Shaun Wright, James G. Kantarevic, Jasmin Med Care Original Articles Until recently, the options for summarizing Canadian patient complexity were limited to health risk predictive modeling tools developed outside of Canada. This study aims to validate a new model created by the Canadian Institute for Health Information (CIHI) for Canada’s health care environment. RESEARCH DESIGN: This was a cohort study. SUBJECTS: The rolling population eligible for coverage under Ontario’s Universal Provincial Health Insurance Program in the fiscal years (FYs) 2006/2007–2016/2017 (12–13 million annually) comprised the subjects. MEASURES: To evaluate model performance, we compared predicted cost risk at the individual level, on the basis of diagnosis history, with estimates of actual patient-level cost using “out-of-the-box” cost weights created by running the CIHI software “as is.” We next considered whether performance could be improved by recalibrating the model weights, censoring outliers, or adding prior cost. RESULTS: We were able to closely match model performance reported by CIHI for their 2010–2012 development sample (concurrent R(2)=48.0%; prospective R(2)=8.9%) and show that performance improved over time (concurrent R(2)=51.9%; prospective R(2)=9.7% in 2014–2016). Recalibrating the model did not substantively affect prospective period performance, even with the addition of prior cost and censoring of cost outliers. However, censoring substantively improved concurrent period explanatory power (from R(2)=53.6% to 66.7%). CONCLUSIONS: We validated the CIHI model for 2 periods, FYs 2010/2011–2012/2013 and FYs 2014/2015—2016/2017. Out-of-the-box model performance for Ontario was as good as that reported by CIHI for the development sample based on 3-province data (British Columbia, Alberta, and Ontario). We found that performance was robust to variations in model specification, data sources, and time. Lippincott Williams & Wilkins 2019-11 2019-09-18 /pmc/articles/PMC6798736/ /pubmed/31567859 http://dx.doi.org/10.1097/MLR.0000000000001203 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Original Articles
Li, Yin
Weir, Sharada
Steffler, Mitch
Shaikh, Shaun
Wright, James G.
Kantarevic, Jasmin
Using Diagnoses to Estimate Health Care Cost Risk in Canada
title Using Diagnoses to Estimate Health Care Cost Risk in Canada
title_full Using Diagnoses to Estimate Health Care Cost Risk in Canada
title_fullStr Using Diagnoses to Estimate Health Care Cost Risk in Canada
title_full_unstemmed Using Diagnoses to Estimate Health Care Cost Risk in Canada
title_short Using Diagnoses to Estimate Health Care Cost Risk in Canada
title_sort using diagnoses to estimate health care cost risk in canada
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798736/
https://www.ncbi.nlm.nih.gov/pubmed/31567859
http://dx.doi.org/10.1097/MLR.0000000000001203
work_keys_str_mv AT liyin usingdiagnosestoestimatehealthcarecostriskincanada
AT weirsharada usingdiagnosestoestimatehealthcarecostriskincanada
AT stefflermitch usingdiagnosestoestimatehealthcarecostriskincanada
AT shaikhshaun usingdiagnosestoestimatehealthcarecostriskincanada
AT wrightjamesg usingdiagnosestoestimatehealthcarecostriskincanada
AT kantarevicjasmin usingdiagnosestoestimatehealthcarecostriskincanada